secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001628280-24-042118
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix appoints Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
-------------------------------------------------------------------------------

- Dr. Magovčević-Liebisch appointed effective Oct 2, 2024 as Class III director with term expiring at 2026 annual meeting.
- Received initial equity award valued at $400,000 (60% stock options, 40% RSUs) vesting over three years.
- She serves as President and CEO of Vigil Neuroscience, with over 25 years biopharma experience.
- Appointed to the Compensation Committee of the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000162828024042118/0001628280-24-042118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000162828024042118/qtrx-20241002.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-042118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer